CLASS II ONGOING Device recall · Reported 7 Jun 2023 · FDA Enforcement Report

Quadrox -i Neonatal, Oxygenator used during cardiopulmonary bypass recalled

Maquet Medical Systems U is recalling Quadrox -i Neonatal, Oxygenator used during cardiopulmonary bypass, distributed nationwide in the US. The recall was initiated on 18 May 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel Item No. UDI HMO 10000-USA 701070412 4058863154473 HMO 11000-USA 701070416 4058863154558 All lots
Quantity recalled0 (US)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1660-2023
FDA event ID
92006
Recalling firm
Maquet Medical Systems U, Wayne, NJ
Classification
Class II
Status
Ongoing
Recall initiated
18 May 2023
FDA classified
30 May 2023
Reported
7 Jun 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

18 May 2023Recall initiated by company
30 May 2023Classified by FDA+12 days
7 Jun 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product packaging may exhibit small pinholes which may not be visible to the unaided eye, compromising the sterile barrier of the packaging. Exposure to non-sterile device may result in inflammation, infection, sepsis, and ischemia.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

QUADROX -i Neonatal, Oxygenator used during cardiopulmonary bypass Model Item No. HMO 10000-USA 701070412 HMO 11000-USA 701070416

Where it was distributed

Nationwide domestic distribution

Nationwide

Questions about this recall

Is Quadrox -i Neonatal, Oxygenator used during cardiopulmonary bypass recalled?

Yes. Maquet Medical Systems U recalled Quadrox -i Neonatal, Oxygenator used during cardiopulmonary bypass on 18 May 2023. The recall is Class II and its status is Ongoing. Recall number Z-1660-2023.

Why was it recalled?

Product packaging may exhibit small pinholes which may not be visible to the unaided eye, compromising the sterile barrier of the packaging. Exposure to non-sterile device may result in inflammation, infection, sepsis, and ischemia.

Which lots are affected?

Model Item No. UDI HMO 10000-USA 701070412 4058863154473 HMO 11000-USA 701070416 4058863154558 All lots

Where was it sold?

Nationwide domestic distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Maquet Medical Systems U

All 41

Other Other Medical Devices recalls

All 13,778